OTC Small Package Exemptions To Be Handled Via Monograph Process - FDA
This article was originally published in The Tan Sheet
Executive Summary
Cosmetic-drug small package exemptions from the OTC labeling final rule should be addressed through the monograph process, FDA tells the Cosmetic, Toiletry & Fragrance Association in a Feb. 4 letter.
You may also be interested in...
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.